Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 20, 2024

SELL
$1.5 - $3.07 $828 - $1,694
-552 Reduced 58.6%
390 $0
Q3 2023

Nov 13, 2023

SELL
$1.5 - $3.07 $828 - $1,694
-552 Reduced 58.6%
390 $0
Q2 2023

May 20, 2024

SELL
$1.79 - $2.9 $893 - $1,447
-499 Reduced 34.63%
942 $2,000
Q2 2023

Aug 04, 2023

SELL
$1.79 - $2.9 $893 - $1,447
-499 Reduced 34.63%
942 $2,000
Q1 2023

May 20, 2024

BUY
$2.65 - $3.81 $3,818 - $5,490
1,441 New
1,441 $4,000
Q3 2017

Nov 15, 2017

BUY
$2.22 - $2.73 $3,199 - $3,933
1,441 New
1,441 $5,000
Q3 2017

Nov 14, 2017

SELL
$2.22 - $2.73 $2,333 - $2,869
-1,051 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
1,051
1,051 $2,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $253M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.